Melanoma PBMC

All filters

Format

Format

Format
Volume

Volume

Volume
Condition

Condition

Condition

Start typing to see matching condition.

Most stocked

Donor Demographics

Donor Demographics

Gender
Age
Race

Start typing to see matching race.

Country
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot # / SO#

Start typing to see matching Lot # / SO#.

Patient ID

Start typing to see matching Patient ID.

27 lots match
27 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Melanoma PBMC 79154 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212099PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79156 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212101PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79155 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212100PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79158 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212103PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79157 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212102PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79160 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212105PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79159 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212104PBMC10M cellsMelanomaSkin cancer of the right lower legNo27.02NoNoNoStoredIn Stock
$765
Melanoma PBMC 79192 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine Melanoma Ukraine 2026 — — — — — — — — — 212170PBMC10M cellsMelanomaSkin cancer of the right forearmNo42.43NoNoNoStoredIn Stock
$765
Melanoma PBMC 79194 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine Melanoma Ukraine 2026 — — — — — — — — — 212172PBMC10M cellsMelanomaSkin cancer of the right forearmNo42.43NoNoNoStoredIn Stock
$765
Melanoma PBMC 79193 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine Melanoma Ukraine 2026 — — — — — — — — — 212171PBMC10M cellsMelanomaSkin cancer of the right forearmNo42.43NoNoNoStoredIn Stock
$765
Melanoma PBMC 79195 — Female 46-60 Caucasian Cryopreserved 1.5 mL 1 10M Amlodipine Melanoma Ukraine 2026 — — — — — — — — — 212173PBMC10M cellsMelanomaSkin cancer of the right forearmNo42.43NoNoNoStoredIn Stock
$765
Melanoma PBMC 79173 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212186PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79175 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212188PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79174 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212187PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79177 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212190PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79176 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212189PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79179 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212192PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79178 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Enalapril Melanoma Ukraine 2026 — — — — — — — — — 212191PBMC10M cellsMelanomaSkin cancer of the right footNo26.54NoNoNoStoredIn Stock
$765
Melanoma PBMC 79137 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications Melanoma Ukraine 2026 — — — — — — — — — 212235PBMC10M cellsMelanomaSkin cancer of the left shoulderNo25.25NoNoNoStoredIn Stock
$765
Melanoma PBMC 79138 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications Melanoma Ukraine 2026 — — — — — — — — — 212236PBMC10M cellsMelanomaSkin cancer of the left shoulderNo25.25NoNoNoStoredIn Stock
$765
Melanoma PBMC 79140 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications Melanoma Ukraine 2026 — — — — — — — — — 212238PBMC10M cellsMelanomaSkin cancer of the left shoulderNo25.25NoNoNoStoredIn Stock
$765
Melanoma PBMC 79139 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications Melanoma Ukraine 2026 — — — — — — — — — 212237PBMC10M cellsMelanomaSkin cancer of the left shoulderNo25.25NoNoNoStoredIn Stock
$765
Melanoma PBMC 79141 — Male 46-60 Caucasian Cryopreserved 1.5 mL 1 10M No medications Melanoma Ukraine 2026 — — — — — — — — — 212239PBMC10M cellsMelanomaSkin cancer of the left shoulderNo25.25NoNoNoStoredIn Stock
$765
Melanoma PBMC 79327 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212283PBMC10M cellsMelanomaSkin cancer of the anterior abdominal wallNo28.73NoNoNoStoredIn Stock
$765
Melanoma PBMC 79326 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Clopidogrel Melanoma Ukraine 2026 — — — — — — — — — 212282PBMC10M cellsMelanomaSkin cancer of the anterior abdominal wallNo28.73NoNoNoStoredIn Stock
$765

Showing 1–25 of 27 lots

About Melanoma PBMC

Melanoma PBMC are sourced from consented donors with documented melanoma. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Melanoma research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Melanoma
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Donor Stratification

Cohort characteristics include diagnosis and documented clinical phenotype, medication history, comorbidities and demographics.

Processing specifications

Anticoagulant
Confirmed per lot on request
Isolation
Density-gradient centrifugation (SepMate™); optional RBC lysis
Processing window
Processed within ~24 hours of collection unless otherwise stated
Cryopreservation
Cryopreservation medium with 10% DMSO; controlled-rate freezing (−1 °C/min)
Storage
Vapor-phase liquid nitrogen
Count and viability
Automated dual-fluorescence cell counter; cells per vial listed per lot
Aliquot sizes
5 × 10⁶ cells (vial)1 × 10⁷ cells (vial)5 × 10⁷ cells (vial)2 × 10⁹ cells (bulk vials)

From Sanguine's processing protocols. View protocols

Donor and clinical data in these lots

Fields recorded on the 27 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.

Donor

Sex
27 of 27 lots
Age
27 of 27 lots
Race
27 of 27 lots
BMI
27 of 27 lots

Clinical history

Primary diagnosis
27 of 27 lots
Current medications
27 of 27 lots
Allergies
27 of 27 lots
Infectious disease history
27 of 27 lots

Collection

Collection date
27 of 27 lots
Country of collection
27 of 27 lots

Need a field that isn't listed, such as disease stage or time since diagnosis?

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Melanoma PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information